M&A Deal Summary |
|
|---|---|
| Date | 2011-07-07 |
| Target | Salient Surgical Technologies |
| Sector | Medical Products |
| Buyer(s) | Medtronic |
| Sellers(s) | Nexus Life Science Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 525M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1949 |
| Sector | Medical Products |
| Employees | 95,000 |
| Revenue | 32.4B USD (2024) |
Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 27 of 59 |
| Sector (Medical Products) | 24 of 52 |
| Type (Add-on Acquisition) | 27 of 57 |
| State (New Hampshire) | 1 of 1 |
| Country (United States) | 24 of 44 |
| Year (2011) | 3 of 3 |
| Size (of disclosed) | 10 of 36 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-07-07 |
PEAK Surgical
Palo Alto, California, United States PEAK Surgical, Inc. is a medical device company that has developed the PEAK PlasmaBlade®, a new tissue dissection device based on a proprietary technology that represents an important advance in advanced energy surgical technologies. The PlasmaBlades are a family of disposable cutting devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral damage. These surgical devices come together with the PULSAR® Generator, which supplies pulsed plasma radiofrequency energy to the PlasmaBlades, to form the PEAK® Surgery System. |
Buy | $120M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-11-17 |
Physio-Control
Redmond, Washington, United States Physio-Control, Inc. develops, manufactures and markets monitors/defibrillators, automated external defibrillators (AEDs) and CPR-assist devices along with data management and support services. |
Sell | $487M |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2001 |
| Size | Small |
| Type | Sector Focused |
Nexus Life Science Partners is a private equity firm that targets private and public healthcare companies located within the United States and around the world. The Firm's focus is on the growth segments of the healthcare industry. In particular, Nexus looks for product-driven life sciences companies developing breakthrough therapeutics for clinical needs, positively altering disease course and associated costs. The firm seeks for each private investment a potential for liquidity within 24 months after initial investment, as well as a 2-3 times return on invested capital. Nexus Life Science Partners was formed in 2001, and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 22 |
| Sector (Medical Products) | 2 of 3 |
| Type (Add-on Acquisition) | 8 of 10 |
| State (New Hampshire) | 1 of 1 |
| Country (United States) | 15 of 19 |
| Year (2011) | 3 of 4 |
| Size (of disclosed) | 5 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-05-16 |
Orthovita
Malvern, Pennsylvania, United States Orthovita is a unique spine/orthopedic surgical biomaterials company offering advanced bone regeneration and soft tissue healing technologies. Their experience lies in developing and distributing novel, high-tech, synthetic-based biomaterial products. Orthovita currently has four key commercial product platforms: Vitoss Bone Graft Substitute, Vitagel Surgical Hemostat, Cortoss Synthetic Cortical Bone, and Imbibe Delivery and Disposable Systems. |
Sell | $316M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-09-19 |
Calypso Medical Technologies
Seattle, Washington, United States Calypso Medical Technologies is a medical device company. |
Sell | $10M |
